The DOI matches its Crossref record; 264 of the 264 references it cites were found in a registry or an index.
Strategies for optimizing the response of cancer and normal tissues to radiation
Open accessAbstract
Approximately 50% of all patients with cancer receive radiation therapy at some point during the course of their treatment, and the majority of these patients are treated with curative intent. Despite recent advances in the planning of radiation treatment and the delivery of image-guided radiation therapy, acute toxicity and potential long-term side effects often limit the ability to deliver a sufficient dose of radiation to control tumours locally. In the past two decades, a better understanding of the hallmarks of cancer and the discovery of specific signalling pathways by which cells respond to radiation have provided new opportunities to design molecularly targeted therapies to increase the therapeutic window of radiation therapy. Here, we review efforts to develop approaches that could improve outcomes with radiation therapy by increasing the probability of tumour cure or by decreasing normal tissue toxicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–264 of 264
Sarcar, B., Kahali, S., Prabhu, A. H., Shumway, S. D., Xu, Y., Demuth, T., & Chinnaiyan, P. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0469 · Cited by 110
Hyperbaric oxygenation for tumour sensitisation to radiotherapy
Bennett, M., Feldmeier, J., Smee, R., & Milross, C. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005007.pub3 · Cited by 109
Future Strategies for Mitigation and Treatment of Chronic Radiation-Induced Normal Tissue Injury
Moulder, J. E., & Cohen, E. P. (2007) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2006.11.010 · Cited by 106
Tumor Cell Radiosensitivity Is a Major Determinant of Tumor Response to Radiation
Gerweck, L. E., Vijayappa, S., Kurimasa, A., Ogawa, K., & Chen, D. J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0533 · Cited by 106
Phase II Study of Palifermin and Concurrent Chemoradiation in Head and Neck Squamous Cell Carcinoma
Brizel, D. M., Murphy, B. A., Rosenthal, D. I., Pandya, K. J., Glück, S., Brizel, H. E., Meredith, R. F., Berger, D. P., Chen, M.-G., & Mendenhall, W. M. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.7349 · Cited by 103
FARRELL, K. L. R. C. L. (1999) · International Journal of Radiation Biology · doi:10.1080/095530099140258 · Cited by 103
Molteni, A., Wolfe, L. F., Ward, W. F., Ts'ao, C.-H., Brizio-Molteni, L., Veno, P. A., Fish, B. L., Taylor, J. M., Quintanilla, N., Herndon, B., et al. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207780618777 · Cited by 102
Relationship between DNA damage, rejoining and cell killing by radiation in mammalian cells
Núñez, M. I., McMillan, T. J., Valenzuela, M. T., de Almodóvar, J. M. R., & Pedraza, V. (1996) · Radiotherapy and Oncology · doi:10.1016/0167-8140(96)01732-x · Cited by 100
Regulatory T Cells in Radiotherapeutic Responses
Schaue, D., Xie, M. W., Ratikan, J. A., & McBride, W. H. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00090 · Cited by 99
Modulating the tumor microenvironment to increase radiation responsiveness
Karar, J., & Maity, A. M. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.21.9988 · Cited by 99
Williams, J. P., Hernady, E., Johnston, C. J., Reed, C., Fenton, B. M., Okunieff, P., & Finkelstein, J. N. (2004) · Radiation Research · doi:10.1667/rr3168 · Cited by 98
p53 Functions in Endothelial Cells to Prevent Radiation-Induced Myocardial Injury in Mice
Lee, C., Moding, E. J., Cuneo, K. C., Li, Y., Sullivan, J. M., Mao, L., Washington, I. R., Jeffords, L. B., Rodrigues, R. C., Ma, Y., et al. (2012) · Science Signaling · doi:10.1126/scisignal.2002918 · Cited by 97
Self-citationArcasoy, M. O., Amin, K., Chou, S.-C., Haroon, Z. A., Varia, M. A., & Raleigh, J. A. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.20.11.1 · Cited by 95
Uckun, F. M., Souza, L., Waddick, K., Wick, M., & Song, C. (1990) · Blood · doi:10.1182/blood.v75.3.638.638 · Cited by 94
Therapeutic Advantage of Hypoxic Cells in Tumors: A Theoretical Study
Brown, J. M., & Koong, A. C. (1991) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/83.3.178 · Cited by 91
Hypoxia in Models of Lung Cancer: Implications for Targeted Therapeutics
Graves, E. E., Vilalta, M., Cecić, I., Erler, J. T., Tran, P. T., Felsher, D. W., Sayles, L. C., Sweet-Cordero, A., Le, Q., & Giaccia, A. J. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1206 · Cited by 91
Targeting SDF-1/CXCR4 to inhibit tumour vasculature for treatment of glioblastomas
Tseng, D., Vasquez-Medrano, D. A., & Brown, J. M. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.169 · Cited by 90
Phase I Study of Vandetanib With Radiotherapy and Temozolomide for Newly Diagnosed Glioblastoma
Drappatz, J., Norden, A. D., Wong, E. T., Doherty, L. M., LaFrankie, D. C., Ciampa, A. S., Kesari, S., Sceppa, C., Gerard, M., Phan, P., et al. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.07.1741 · Cited by 86
Radiation-induced kidney injury: a role for chronic oxidative stress?
Robbins, M. E. C., Zhao, W., Davis, C. S., Toyokuni, S., & Bonsib, S. M. (2002) · Micron · doi:10.1016/s0968-4328(01)00006-3 · Cited by 85
Carpenter, M., Epperly, M. W., Agarwal, A., Nie, S., Hricisak, L., Niu, Y., & Greenberger, J. S. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302468 · Cited by 84
Loss of atm radiosensitizes multiple p53 null tissues.
Westphal, C. H., Hoyes, K. P., Canman, C. E., Huang, X., Kastan, M. B., Hendry, J. H., & Leder, P. (1998) · PubMed · Cited by 81
Self-citationWEE1 Kinase Inhibition Enhances the Radiation Response of Diffuse Intrinsic Pontine Gliomas
Caretti, V., Hiddingh, L., Lagerweij, T., Schellen, P., Koken, P. W., Hulleman, E., van Vuurden, D. G., Vandertop, W. P., Kaspers, G. J. L., Noske, D. P., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0735 · Cited by 78
Wang, J., Boerma, M., Fu, Q., Kulkarni, A., Fink, L. M., & Hauer‐Jensen, M. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.03.036 · Cited by 77
Advances in Radiation Oncology
Elshaikh, M. A., Ljungman, M. E., Haken, R. K. T., & Lichter, A. S. (2005) · Annual Review of Medicine · doi:10.1146/annurev.med.57.121304.131431 · Cited by 76
Melatonin stimulates glutathione peroxidase activity in human chorion
Okatani, Y., Wakatsuki, A., Shinohara, K., Kaneda, C., & Fukaya, T. (2001) · Journal of Pineal Research · doi:10.1034/j.1600-079x.2001.300402.x · Cited by 76
Plasticity and Tissue Regenerative Potential of Bone Marrow-Derived Cells
Vieyra, D. S., Jackson, K. A., & Goodell, M. A. (2005) · Stem Cell Reviews and Reports · doi:10.1385/scr:1:1:065 · Cited by 75
Radiation therapy and Toll-like receptor signaling: implications for the treatment of cancer
Roses, R. E., Xu, M., Koski, G. K., & Czerniecki, B. J. (2008) · Oncogene · doi:10.1038/sj.onc.1210909 · Cited by 74
Haydont, V., Gilliot, O., Rivera, S., Bourgier, C., François, A., Aigueperse, J., Bourhis, J., & Vozenin, M. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.03.044 · Cited by 74
Kozin, S. V., Duda, D. G., Munn, L. L., & Jain, R. K. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs239 · Cited by 73
Moulder, J. E., Fish, B. L., & Cohen, E. (2003) · Current Pharmaceutical Design · doi:10.2174/1381612033455422 · Cited by 72
Impact of Stromal Sensitivity on Radiation Response of Tumors
Budach, W., Taghian, A. G., Freeman, J., Gioioso, D., & Suit, H. D. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.12.988 · Cited by 72
Rationale for chemoradiotherapy
Nishimura, Y. (2004) · International Journal of Clinical Oncology · doi:10.1007/s10147-004-0443-z · Cited by 71
Enhancing radiosensitivity: Targeting the DNA repair pathways
Jorgensen, T. J. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.8.8304 · Cited by 70
The Inhibition and Treatment of Breast Cancer with Poly (ADP-ribose) Polymerase (PARP-1) Inhibitors
Soto, J. A. D., Wang, X., Tominaga, Y., Wang, R., Cao, L., Qiao, W., Li, C., Xu, X., Skoumbourdis, A. P., Prindiville, S. A., et al. (2006) · International Journal of Biological Sciences · doi:10.7150/ijbs.2.179 · Cited by 69
Wang, Y., Meng, A., Lang, H., Brown, S. A., Konopa, J. L., Kindy, M. S., Schmiedt, R. A., THOMPSON, J. S., & Zhou, D. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0591 · Cited by 67
Le, Q., Fisher, R., Oliner, K. S., Young, R. J., Cao, H., Kong, C. S., Graves, E. E., Hicks, R. J., McArthur, G. A., Peters, L., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2094 · Cited by 67
Re: Impact of Stromal Sensitivity on Radiation Response of Tumors
Budach, W. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.23.1842 · Cited by 67
New rationales for using TGFbetainhibitors in radiotherapy
Andarawewa, K. L., Paupert, J., Pal, A., & Barcellos‐Hoff, M. H. (2007) · International Journal of Radiation Biology · doi:10.1080/09553000701711063 · Cited by 66
Influence of Tumor Cell and Stroma Sensitivity on Tumor Response to Radiation
Ogawa, K., Boucher, Y., Kashiwagi, S., Fukumura, D., Chen, D. J., & Gerweck, L. E. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4498 · Cited by 66
Hauser, S. H., Calorini, L., Wazer, D. E., & Gattoni‐Celli, S. (1993) · PubMed · Cited by 63
Impact of Stromal Sensitivity on Radiation Response of Tumors Implanted in SCID Hosts Revisited
Garcı́a-Barros, M., Thin, T. H., Maj, J., Cordon‐Cardo, C., Haimovitz‐Friedman, A., FUKS, Z. Y., & Kolesnick, R. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1871 · Cited by 63
Wang, J., Zheng, H., Ou, X., Albertson, C., Fink, L. M., Herbert, J., & Hauer‐Jensen, M. (2004) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2004.00960.x · Cited by 61
Ceramide mediates radiation-induced death of endothelium
Lin, X., FUKS, Z. Y., & Kolesnick, R. (2000) · Critical Care Medicine · doi:10.1097/00003246-200004001-00010 · Cited by 60
Delta-Like Ligand 4–Notch Blockade and Tumor Radiation Response
Liu, S. K., Bham, S. A. S., Fokas, E., Beech, J. S., Im, J. H., Cho, S., Harris, A. L., & Muschel, R. J. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr419 · Cited by 60
Zerp, S. F., Stoter, R., Kuipers, G. K., Yang, D., Lippman, M. E., BLITTERSWIJK, W. J. V., Bartelink, H. G. M. M., Rooswinkel, R. W., Lafleur, M. V. M., & Verheij, M. (2009) · Radiation Oncology · doi:10.1186/1748-717x-4-47 · Cited by 60
Ryu, S., Kolozsvary, A. J. J., Jenrow, K. A., Brown, S. L., & Kim, J. H. (2006) · Journal of Neuro-Oncology · doi:10.1007/s11060-006-9256-4 · Cited by 59
Burdelya, L. G., Komarova, E. A., Hill, J. E., Browder, T. D., Tararova, N. D., Mavrakis, L. A., DiCorleto, P. E., Folkman, J., & Gudkov, A. V. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1223 · Cited by 57
Current status of radiotherapy with proton and light ion beams
Greco, C., & Wolden, S. L. (2007) · Cancer · doi:10.1002/cncr.22542 · Cited by 56
Wang, J., Albertson, C., Zheng, H., Fink, L. M., Herbert, J., & Hauer‐Jensen, M. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1612954 · Cited by 52
Berk, L. B., Berkey, B. A., Rich, T. A., Hrushesky, W. J. M., Blask, D. E., Gallagher, M., Kudrimoti, M. R., McGarry, R. C., Suh, J. H., & Mehta, M. P. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.01.012 · Cited by 52
Bertho, J., Frick, J., Prat, M., Demarquay, C., Dudoignon, N., Trompier, F., Gorin, N. C., Thierry, D., & Gourmelon, P. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.03.045 · Cited by 50
No Significant Endothelial Apoptosis in the Radiation-Induced Gastrointestinal Syndrome
Schuller, B. W., Rogers, A. B., Cormier, K. S., Riley, K. J., Binns, P. J., Julius, R. L., Hawthorne, M. F., & Coderre, J. A. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.12.069 · Cited by 50
Stem Cell Therapy to Reduce Radiation-Induced Normal Tissue Damage
Coppes, R. P., van der Goot, A., & Lombaert, I. M. A. (2009) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2008.11.005 · Cited by 48
AT-101, a Pan-Bcl-2 Inhibitor, Leads to Radiosensitization of Non-small Cell Lung Cancer
Moretti, L., Li, B., Kim, K. W., Chen, H., & Lü, B. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181d6e08e · Cited by 45
Mcl-1 blocks radiation-induced apoptosis and inhibits clonogenic cell death.
Skvara, H., Thallinger, C., Wacheck, V., et al. (2005) · PubMed · Cited by 42
Ahn, G., & Brown, J. M. (2009) · Cell Cycle · doi:10.4161/cc.8.7.8075 · Cited by 39
Raso, A., Vecchio, D., Cappelli, E., Ropolo, M., Poggi, A. D., Nozza, P., Biassoni, R., Mascelli, S., Capra, V., Kalfas, F., et al. (2012) · Brain Pathology · doi:10.1111/j.1750-3639.2012.00566.x · Cited by 35
Amelioration of Radiation Nephropathy by Acetylsalicylic Acid
Verheij, M., Stewart, F. A., Oussoren, Y. G., Weening, J. J., & Dewit, L. G. H. (1995) · International Journal of Radiation Biology · doi:10.1080/09553009514550701 · Cited by 35
Indicators of free radical activity in patients developing radiation pneumonitis
Jack, C. I. A., Bottier, B., Jackson, M. J., Cassapi, L., Fraser, W. D., & Hind, C. R. K. (1996) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(95)00209-x · Cited by 34
Combination Approaches to Immunotherapy: the Radiotherapy Example
Gough, M. J., & Crittenden, M. R. (2009) · Immunotherapy · doi:10.2217/imt.09.64 · Cited by 29
Teng, L., Jin, K., He, K., Wang, H., Cao, J., & Yu, D.-C. (2010) · Journal of the Chinese Medical Association · doi:10.1016/s1726-4901(10)70062-9 · Cited by 28
Akagi, T., Ushinohama, K., Ikesue, S., Yukawa, E., Higuchi, S., Hamase, K., Zaitsu, K., & Ohdo, S. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.055657 · Cited by 16
Location, Location, Location-Makes All the Difference for Hypoxia in Lung Tumors
Maity, A. M., & Koumenis, C. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2004 · Cited by 13
Microarray determination of Bcl-2 family protein inhibition sensitivity in breast cancer cells
Hudson, S., Halleran, D. R., Nevaldine, B. H., Shapiro, A., Hutchison, R. E., & Hahn, P. J. (2013) · Experimental Biology and Medicine · doi:10.1177/1535370212474582 · Cited by 4
Cited by
Targeting macrophages: therapeutic approaches in cancer
Cassetta, L., & Pollard, J. W. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.169 · Cited by 2,048
De Ruysscher, D., Niedermann, G., Burnet, N. G., Siva, S., Lee, A. W. M., & Hegi-Johnson, F. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0064-5 · Cited by 868
Biological response of cancer cells to radiation treatment
Baskar, R., Dai, J., Wenlong, N., Yeo, R., & Yeoh, K.-W. (2014) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2014.00024 · Cited by 638
The interaction of anticancer therapies with tumor-associated macrophages
Mantovani, A., & Allavena, P. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20150295 · Cited by 616
A short guide for medical professionals in the era of artificial intelligence
Meskó, B., & Görög, M. (2020) · npj Digital Medicine · doi:10.1038/s41746-020-00333-z · Cited by 409
Metadata
- Authors
- Moding, E. J., Kastan, M. B., & Kirsch, D. G.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2013-07
- Volume
- 12
- Issue
- 7
- Pages
- 526-542
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1982415526
- Cited by
- 461
- References
- 264
- FWCI
- 3.94
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.